We have seen 78 institutional investors add shares of $CAPR stock to their portfolio, and 36 decrease their positions in their most recent quarter.

Capricor Therapeutics shares are trading lower by 6.05% during Thursday's session. The company earlier commenced its public offering of common stock. Wall Street veteran Chris Capre is going live ...